Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Marvin Meyer
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Concepts & Ideas
Chemicals & Drugs
Procedures
Physiology
Living Beings
Sign-in to see full Profile
Network (preview)
32
Straughn, Arthur
7
Shah, Vinod
6
Williams, Roger
5
Wood, Christopher
4
Patrick, Kennerly
4
Mhatre, RM
3
Dalton, James
3
Golub, Allyn
3
Lesko, Lawrence
2
Chen, Mei-Ling
2
Chen, Yixin
2
McCall, Troy
1
Meibohm, Bernd
1
Patnaik, Rabi
1
Veng-Pedersen, Peter
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Marvin Meyer (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2002: Dalton James T; Yates Charles R; Yin Donghua; Straughn Arthur; Marcus Stuart L; Golub Allyn L; Meyer Marvin C
Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer.
The Journal of pharmacology and experimental therapeutics 2002;301(2):507-12.
-
2002: Chen Yixin; Jiao Tianjie; McCall Troy W; Baichwal Anand R; Meyer Marvin C
Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets.
Pharmaceutical development and technology 2002;7(3):373-9.
-
2001: Meyer M C; Straughn A B; Mhatre R M; Shah V P; Chen M L; Williams R L; Lesko L J
Variability in the bioavailability of phenytoin capsules in males and females.
Pharmaceutical research 2001;18(3):394-7.
-
2001: Meyer M C
United States Food and Drug Administration requirements for approval of generic drug products.
The Journal of clinical psychiatry 2001;62 Suppl 5():4-9; discussion 23-4.
-
2000: Meyer M C; Straughn A B; Mhatre R M; Hussain A; Shah V P; Bottom C B; Cole E T; Lesko L L; Mallinowski H; Williams R L
The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules.
Pharmaceutical research 2000;17(8):962-6.
-
2000: Meibohm B; Zhang W; Beierle I; Meyer M C
Epistaxis associated with elevation of INR in a patient switched to generic warfarin--another view.
Pharmacotherapy 2000;20(7):866-9; discussion 869-71.
-
2000: Meyer M C; Straughn A B; Jarvi E J; Patrick K S; Pelsor F R; Williams R L; Patnaik R; Chen M L; Shah V P
Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability.
Pharmaceutical research 2000;17(4):381-4.
-
2000: Veng-Pedersen P; Gobburu J V; Meyer M C; Straughn A B
Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach.
Biopharmaceutics & drug disposition 2000;21(1):1-6.
-
1999: Meyer M C; Jarvi E J; Straughn A B; Pelsor F R; Williams R L; Shah V P
Bioequivalence of immediate-release theophylline capsules.
Biopharmaceutics & drug disposition 1999;20(9):417-9.
-
1999: Chen Y; McCall T W; Baichwal A R; Meyer M C
The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms.
Journal of controlled release : official journal of the Controlled Release Society 1999;59(1):33-41.
-
1999: Dalton J T; Meyer M C; Golub A L
Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(4):432-5.
-
1999: Kidd R S; Straughn A B; Meyer M C; Blaisdell J; Goldstein J A; Dalton J T
Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele.
Pharmacogenetics 1999;9(1):71-80.
-
1999: Dalton J T; Zhou D; Mukherjee A; Young D; Tolley E A; Golub A L; Meyer M C
Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.
Pharmaceutical research 1999;16(2):288-95.
-
1998: Meyer M C; Straughn A B; Mhatre R M; Shah V P; Williams R L; Lesko L J
The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets.
Pharmaceutical research 1998;15(11):1787-91.
-
1998: Meyer M C
Generic drug product equivalence: current status.
The American journal of managed care 1998;4(8):1183-9; quiz 1190-2.
-
1998: Meyer M C; Straughn A B; Mhatre R M; Shah V P; Williams R L; Lesko L J
Lack of in vivo/in vitro correlations for 50 mg and 250 mg primidone tablets.
Pharmaceutical research 1998;15(7):1085-9.
-
1995: Meyer M C; Cloyd J; Garnett W R; Holmes G L; Schiffer J R
Practical considerations in anticonvulsant therapy--Part 2.
American pharmacy 1995;NS35(9):31-6, 40.
-
1995: Meyer M C; Cloyd J; Garnett W R; Holmes G L; Schiffer J R
Practical considerations in anticonvulsant therapy--Part 1.
American pharmacy 1995;NS35(7):22-6.
-
1993: Meyer M C; Straughn A B
Biopharmaceutical factors in seizure control and drug toxicity.
American journal of hospital pharmacy 1993;50(12 Suppl 5):S17-22.
-
1993: Meyer M C; Straughn A B; Jarvi E J; Wood G C; Vashi V I; Hepp P; Hunt J
The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans.
Pharmaceutical research 1993;10(7):1037-45.
-
1992: Meyer M C; Straughn A B; Jarvi E J; Wood G C; Pelsor F R; Shah V P
The bioinequivalence of carbamazepine tablets with a history of clinical failures.
Pharmaceutical research 1992;9(12):1612-6.
-
1991: Betlach C J; Straughn A B; Meyer M C; Bialer M; Vashi V I; Liebermann P; González M A
The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
Pharmaceutical research 1991;8(12):1516-9.
-
1991: Rackley R J; Meyer M C; Straughn A B
Circadian rhythms in theophylline disposition: simulations and observations in the dog.
Journal of pharmaceutical sciences 1991;80(9):824-9.
-
1989: Patrick K S; Jarvi E J; Straughn A B; Meyer M C
Gas chromatographic-mass spectrometric analysis of plasma nifedipine.
Journal of chromatography 1989;495():123-30.
-
1989: Meyer M C; Wood G C; Straughn A B
In vitro and in vivo evaluation of seven 50 mg and 100 mg nitrofurantoin tablets.
Biopharmaceutics & drug disposition 1989;10(3):321-9.
-
1989: Patrick K S; Straughn A B; Jarvi E J; Breese G R; Meyer M C
The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation.
Biopharmaceutics & drug disposition 1989;10(2):165-71.
-
1989: Patrick K S; Markowitz J S; Jarvi E J; Straughn A B; Meyer M C
Gas chromatographic-mass spectrometric analysis of plasma oxybutynin using a deuterated internal standard.
Journal of chromatography 1989;487(1):91-8.
-
1988: Vashi V I; Meyer M C
Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
Journal of pharmaceutical sciences 1988;77(9):760-4.
-
1988: Rackley R J; Meyer M C; Straughn A B
Circadian rhythm in theophylline disposition during a constant-rate intravenous infusion of aminophylline in the dog.
Journal of pharmaceutical sciences 1988;77(8):658-61.
-
1988: Graves D A; Wecker M T; Meyer M C; Straughn A B; Amsel L P; Hinsvark O N; Bhargava A K; Rotenberg K S
Influence of a standard meal on the absorption of a controlled release pseudoephedrine suspension.
Biopharmaceutics & drug disposition 1988;9(3):267-72.
-
1986: Straughn A B; Wood G C; Raghow G; Meyer M C
Bioavailability of seven furosemide tablets in man.
Biopharmaceutics & drug disposition 1986;7(2):113-20.
-
1985: Straughn A B; Wood G C; Raghow G; Meyer M C
Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans.
Journal of pharmaceutical sciences 1985;74(3):335-7.
-
1984: Meyer M C; Straughn A B; Lo M W; Schary W L; Whitney C C
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
The Journal of clinical psychiatry 1984;45(9 Pt 2):15-9.
-
1984: Meyer M C; Straughn A B; Raghow G; Schary W L; Rotenberg K S
Absorption of phenobarbital from tablets and elixir.
Journal of pharmaceutical sciences 1984;73(4):485-8.
-
1983: Ringhand H P; Ritschel W A; Meyer M C; Straughn A B; Cabana B E
Bioavailability of propylthiouracil in humans.
Journal of pharmaceutical sciences 1983;72(12):1409-12.
-
1983: Meyer M C; Raghow G; Straughn A B
Plasma levels of ethaverine after oral administration to humans.
Biopharmaceutics & drug disposition 1983;4(4):401-4.
-
1983: Yau M K; Meyer M C
In vivo-in vitro correlations with a commercial dissolution simulator II: papaverine, phenytoin, and sulfisoxazole.
Journal of pharmaceutical sciences 1983;72(6):681-6.
-
1983: Shah V P; Prasad V K; Alston T; Cabana B E; Gural R P; Meyer M C
Phenytoin I: in vitro-in vivo correlation for 100-mg phenytoin sodium capsules.
Journal of pharmaceutical sciences 1983;72(3):306-8.
-
1982: Straughn A B; Gollamudi R; Meyer M C
Relative bioavailability of acetazolamide tablets.
Biopharmaceutics & drug disposition 1982;3(1):75-82.
-
1982: Meyer M C; Hwang P; Straughn A B; Rotenberg K
HPLC determination of benzthiazide in biologic material.
Biopharmaceutics & drug disposition 1982;3(1):1-9.
-
1981: Raghow G; Meyer M C
High-performance liquid chromatographic assay of tolbutamide and carboxytolbutamide in human plasma.
Journal of pharmaceutical sciences 1981;70(10):1166-8.
-
1981: Yau M K; Meyer M C
In vivo-in vitro correlations with a commercial dissolution simulator. I: Methenamine, nitrofurantoin, and chlorothiazide.
Journal of pharmaceutical sciences 1981;70(9):1017-24.
-
1981: Gollamudi R; Straughn A B; Meyer M C
Urinary excretion of methenamine and formaldehyde: evaluation of 10 methenamine products in humans.
Journal of pharmaceutical sciences 1981;70(6):596-9.
-
1980: Ringhand H P; Ritschel W A; Meyer M C; Straughn A B; Hardt T
Pharmacokinetics of propylthiouracil upon p.o. administration in man.
International journal of clinical pharmacology, therapy, and toxicology 1980;18(11):488-93.
-
1980: Straughn A B; Meyer M C; Raghow G; Rotenberg K
Bioavailability of microsize and ultramicrosize griseofulvin products in man.
Journal of pharmacokinetics and biopharmaceutics 1980;8(4):347-62.
-
1980: Meyer M C; Straughn A B; Lieberman P
A multiple-dose study of sustained-release theophylline and aminophylline.
Chest 1980;78(2):300-3.
Sign-in to see more